NDC 46014-6140 – Uptravi
Selexipag 1.4 mg/1 · Capsule
Product NDC46014-6140
Product details
- Brand name
- Uptravi
- Generic name
- Uptravi
- Labeler
- Excella GmbH & Co. KG
- Dosage form
- Capsule
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketed since
- December 22, 2015
- Listing expires
- December 31, 2026
Active ingredients
- Selexipag 1.4 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 46014-6140-6 | 60 CAPSULE in 1 BOTTLE (46014-6140-6) |
Other Uptravi products
- 46014-6040 Selexipag .4 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-6060 Selexipag .6 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-6100 Selexipag 1 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-6120 Selexipag 1.2 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-6160 Selexipag 1.6 mg/1 · Capsule · Excella GmbH & Co. KG
- 66215-602 Selexipag 200 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-604 Selexipag 400 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-606 Selexipag 600 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-608 Selexipag 800 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-610 Selexipag 1000 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-612 Selexipag 1200 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-614 Selexipag 1400 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.